SCbio announces accelerator program for emerging life science companies, SCbioDrive

February 20, 2024

SCbio, in partnership with MassBio, recently announced its new accelerator program, SCbioDrive, designed to advance emerging companies through expert business curricula, industry guidance and mentorship.

A biannual program, SCbioDrive will select up to six seed-stage therapeutic and medical device companies for an eight-week course, which will consist of seven weeks of virtual instruction followed by one week in person at SCbio facilities in Charleston, S.C. Company founders will complete industry-specific curriculum modules, led by experts from leading companies within the Palmetto State, which will include:

  • Business Planning & Commercialization
  • Fundraising
  • People Strategy & Operations
  • Drug Discovery & Therapeutics
  • Intellectual Property & Legal
  • Regulatory Strategy
  • Business Scaling

The program will conclude with an in-person demo day.

“SCbioDrive will give emerging life science companies a solid foundation of resources, increased access to capital and continued mentorship from a network of established business leaders,” said SCbio President and CEO James Chappell. “We want this program to show entrepreneurs that South Carolina is the state where businesses, at their earliest stages, are set up for success and sustained growth.”

“Our vision for Drive has always been to support diverse founders with exciting science no matter where they are starting their company,” said MassBio CEO & President Kendalle Burlin O’Connell. “We’re pleased to see SCbio take the MassBioDrive model and put a Palmetto State spin on it to accelerate their homegrown startups toward success.”

SCbioDrive will launch this fall. Applications for the inaugural program cohort will be available in June at